BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 35068161)

  • 21. High Expression of BCAR1 by Circulating Tumor Cells and Tumor Tissues Is Predictive of a Poor Prognosis of Early-Stage Lung Adenocarcinoma Potentially Due to Regulation of Epithelial-Mesenchymal Transition.
    Jiang S; Mao C; Jiang B; Tan Q; Deng B
    Technol Cancer Res Treat; 2020; 19():1533033820983086. PubMed ID: 33334252
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Mesenchymal marker and LGR5 expression levels in circulating tumor cells correlate with colorectal cancer prognosis.
    Wang W; Wan L; Wu S; Yang J; Zhou Y; Liu F; Wu Z; Cheng Y
    Cell Oncol (Dordr); 2018 Oct; 41(5):495-504. PubMed ID: 29949050
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Gene expression profiling of single circulating tumor cells in ovarian cancer - Establishment of a multi-marker gene panel.
    Blassl C; Kuhlmann JD; Webers A; Wimberger P; Fehm T; Neubauer H
    Mol Oncol; 2016 Aug; 10(7):1030-42. PubMed ID: 27157930
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Circulating Tumor Cells and Fibronectin 1 in the Prognosis of Nasopharyngeal Carcinoma.
    Yu Y; Lin ZX; Li HW; Luo HQ; Yang DH; Zhou HC; Jiang DX; Zhan DC; Yang L; Liang XY; Yu ZH; Chen ZH
    Technol Cancer Res Treat; 2020; 19():1533033820909911. PubMed ID: 32281480
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Relationship between PRRX1, circulating tumor cells, and clinicopathological parameter in patients with gastric cancer.
    Zhang Y; Yao J; Feng J; Wang S; Yang Z; Huang W; Da M
    J BUON; 2020; 25(3):1455-1462. PubMed ID: 32862590
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Molecular characterization and clinical implications of spindle cells in nasopharyngeal carcinoma: a novel molecule-morphology model of tumor progression proposed.
    Luo W; Yao K
    PLoS One; 2013; 8(12):e83135. PubMed ID: 24349446
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Comparison of the PI3KCA pathway in circulating tumor cells and corresponding tumor tissue of patients with metastatic breast cancer.
    Bredemeier M; Kasimir-Bauer S; Kolberg HC; Herold T; Synoracki S; Hauch S; Edimiris P; Bankfalvi A; Tewes M; Kimmig R; Aktas B
    Mol Med Rep; 2017 May; 15(5):2957-2968. PubMed ID: 28358430
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Real-time in vivo imaging of subpopulations of circulating tumor cells using antibody conjugated quantum dots.
    Kuo CW; Chueh DY; Chen P
    J Nanobiotechnology; 2019 Feb; 17(1):26. PubMed ID: 30728024
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Reduced expression of Dicer11 is associated with poor prognosis in patients with nasopharyngeal carcinoma.
    Liu N; Cui RX; He QM; Huang BJ; Sun Y; Xie D; Zeng J; Wang HY; Ma J
    Med Oncol; 2013 Mar; 30(1):360. PubMed ID: 23307239
    [TBL] [Abstract][Full Text] [Related]  

  • 30. H3K27me3 protein is a promising predictive biomarker of patients' survival and chemoradioresistance in human nasopharyngeal carcinoma.
    Cai MY; Tong ZT; Zhu W; Wen ZZ; Rao HL; Kong LL; Guan XY; Kung HF; Zeng YX; Xie D
    Mol Med; 2011; 17(11-12):1137-45. PubMed ID: 21738951
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Circulating Tumor Cells with Stemness and Epithelial-to-Mesenchymal Transition Features Are Chemoresistant and Predictive of Poor Outcome in Metastatic Breast Cancer.
    Papadaki MA; Stoupis G; Theodoropoulos PA; Mavroudis D; Georgoulias V; Agelaki S
    Mol Cancer Ther; 2019 Feb; 18(2):437-447. PubMed ID: 30401696
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Evaluation of sensitivity and specificity of CanPatrol™ technology for detection of circulating tumor cells in patients with non-small cell lung cancer.
    Li J; Liao Y; Ran Y; Wang G; Wu W; Qiu Y; Liu J; Wen N; Jing T; Wang H; Zhang S
    BMC Pulm Med; 2020 Oct; 20(1):274. PubMed ID: 33081780
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Assessment of the Clinical Utility of Circulating Tumor Cells at Different Time Points in Predicting Prognosis of Patients With Small Cell Lung Cancer: A Meta-Analysis.
    Jiang AM; Zheng HR; Liu N; Zhao R; Ma YY; Bai SH; Tian T; Liang X; Ruan ZP; Fu X; Yao Y
    Cancer Control; 2021; 28():10732748211050581. PubMed ID: 34654345
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Baseline circulating stem-like cells predict survival in patients with metastatic breast Cancer.
    Lee CH; Hsieh JC; Wu TM; Yeh TS; Wang HM; Lin YC; Chen JS; Lee CL; Huang WK; Hung TM; Yen TT; Chan SC; Chou WC; Kuan FC; Hu CC; Chang PH
    BMC Cancer; 2019 Dec; 19(1):1167. PubMed ID: 31791269
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Prognostic value of cancer stem cells, epithelial-mesenchymal transition and circulating tumor cells in lung cancer.
    Pirozzi G; Tirino V; Camerlingo R; La Rocca A; Martucci N; Scognamiglio G; Franco R; Cantile M; Normanno N; Rocco G
    Oncol Rep; 2013 May; 29(5):1763-8. PubMed ID: 23426441
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Expression of MTA1 in nasopharyngeal carcinoma and its correlation with prognosis.
    Yuan T; Zhang H; Liu B; Zhang Q; Liang Y; Zheng R; Deng J; Zhang X
    Med Oncol; 2014 Dec; 31(12):330. PubMed ID: 25416046
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Increased expression of Cks1 protein is associated with lymph node metastasis and poor prognosis in nasopharyngeal carcinoma.
    Xu L; Fan S; Zhao J; Zhou P; Chu S; Luo J; Wen Q; Chen L; Wen S; Wang L; Shi L
    Diagn Pathol; 2017 Jan; 12(1):2. PubMed ID: 28061788
    [TBL] [Abstract][Full Text] [Related]  

  • 38. HER2 expression on tumor-derived extracellular vesicles and circulating tumor cells in metastatic breast cancer.
    Nanou A; Zeune LL; Bidard FC; Pierga JY; Terstappen LWMM
    Breast Cancer Res; 2020 Aug; 22(1):86. PubMed ID: 32787900
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Circulating tumor cells and their advances to promote cancer metastasis and relapse, with focus on glioblastoma multiforme.
    Chistiakov DA; Chekhonin VP
    Exp Mol Pathol; 2018 Oct; 105(2):166-174. PubMed ID: 30028961
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Analysis of Circulating Tumor Cells in Ovarian Cancer and Their Clinical Value as a Biomarker.
    Zhang X; Li H; Yu X; Li S; Lei Z; Li C; Zhang Q; Han Q; Li Y; Zhang K; Wang Y; Liu C; Mao Y; Wang X; Irwin DM; Guo H; Niu G; Tan H
    Cell Physiol Biochem; 2018; 48(5):1983-1994. PubMed ID: 30092594
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.